Digitalisation and Emotional Virtues
Bogoslovska smotra · 16.04.2026 · 95 (5) · 1103-1124
DOI: 10.53745/bs.95.5.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bogoslovska smotra, online erschienen am 16.04.2026. Verfasst von Saša Poljak Lukek und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This article examines how digitalisation through artificial intelligence (AI) and virtual reality (VR) is changing our emotional lives and moral development, with a focus on adolescence. Digitalisation is understood not only as a technological change, but also as a socio-cultural change that reshapes knowledge, relationships, and identity. AI provides tools to simulate empathy, manage emotional regulation and support adaptive coping; while VR creates immersive environments that promote empathy, perspective-taking, and social sensitivity. Adolescence is highlighted as a particularly sensitive phase for these interventions, characterised by neurocognitive plasticity and the formation of a moral identity. Digital technologies can offer the opportunity to cultivate emotional virtues such as resilience, gratitude, and courage. At the same time, however, they harbour risks such as over-reliance on algorithms, emotional superficiality, and overwhelming virtual experiences. The article concludes that AI and VR should not replace human relationships but serve as complementary tools. A humancentred approach is essential to ensure that these technologies promote emotional virtues and contribute to human well-being.
Zitieren
APA
Lukek, S. P., & Valenta, T. (2026). Digitalisation and Emotional Virtues. Bogoslovska smotra, 95(5), 1103-1124. https://doi.org/10.53745/bs.95.5.13
Vancouver
Lukek SP, Valenta T. Digitalisation and Emotional Virtues. Bogoslovska smotra. 2026;95(5):1103-1124. doi:10.53745/bs.95.5.13
BibTeX
@article{Lukek2026,
author = {Lukek, Saša Poljak and Valenta, Tanja},
title = {Digitalisation and Emotional Virtues},
journal = {Bogoslovska smotra},
year = {2026},
volume = {95},
number = {5},
pages = {1103--1124},
doi = {10.53745/bs.95.5.13}
}
EUVIMED